Format

Send to

Choose Destination
See comment in PubMed Commons below
Yonsei Med J. 2010 Sep;51(5):633-40. doi: 10.3349/ymj.2010.51.5.633.

Brain tumor stem cells as therapeutic targets in models of glioma.

Author information

1
Intellectual and Developmental Disability Research Center, UCLA Medical Center, Los Angeles, California, USA.

Abstract

At this time, brain tumor stem cells remain a controversial hypothesis while malignant brain tumors continue to present a dire prognosis of severe morbidity and mortality. Yet, brain tumor stem cells may represent an essential cellular target for glioma therapy as they are postulated to be the tumorigenic cells responsible for recurrence. Targeting oncogenic pathways that are essential to the survival and growth of brain tumor stem cells represents a promising area for developing therapeutics. However, due to the multiple oncogenic pathways involved in glioma, it is necessary to determine which pathways are the essential targets for therapy. Furthermore, research still needs to comprehend the morphogenic processes of cell populations involved in tumor formation. Here, we review research and discuss perspectives on models of glioma in order to delineate the current issues in defining brain tumor stem cells as therapeutic targets in models of glioma.

PMID:
20635435
PMCID:
PMC2908869
DOI:
10.3349/ymj.2010.51.5.633
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Yonsei University College of Medicine Icon for PubMed Central
    Loading ...
    Support Center